Why companies that sell into hospitals must learn to speak the language of hospital executives — or lose every deal to someone who does
There is a meeting happening right now in a hospital somewhere in this country.
A CFO, a CMO, and a VP of Supply Chain are sitting around a conference table. They are not talking about your product. They are talking about a CMS penalty notice that arrived last Thursday. They are talking about what happens to their operating margin if their readmission rate does not move by Q3. They are talking about the TEAM model going mandatory next year and what that means for their orthopedic service line.
Your competitor’s rep is in that meeting.
Not because their product is better than yours. Not because they outpriced you, outmaneuvered you, or got there first. They are in that meeting because when the CFO mentioned HRRP six months ago, your rep nodded politely and pivoted back to the product demo. Their rep stopped, asked a very specific question about which DRGs were driving the penalty, and spent the next twenty minutes sounding less like a vendor and more like someone who had sat on the other side of that table.
That is the only difference.
This is not about sales tactics. It is not about closing techniques, account mapping, or how to get past the gatekeeper. There are enough written about those tactics and strategies. This is about something more fundamental — the gap between companies that sell into healthcare and companies that are trusted by healthcare. The gap between being heard and being taken seriously. The gap between having a great product and actually winning the deal.
That gap has a name.
It is called fluency. And most companies selling into hospitals do not have it.
I spent thirty years on the inside of healthcare — managing budgets, evaluating vendors, sitting in the meetings where the real decisions get made. I have seen extraordinary products lose to mediocre ones because the seller could not speak the language of the executive in the room. I have watched sales teams spend twelve months in a sales cycle that should have taken four, because no one on the team could connect their solution to the right pressure point at the right level of the organization.
I am writing about this because it is a solvable problem. Not through a one-day training. Not through a glossary of healthcare acronyms stapled to the back of your sales playbook. Through a genuine, structural change in how your team understands the market it is operating in.
Fluency is not about memorizing acronyms. It is not about putting your team through a compliance training module or adding a ‘regulatory insights’ slide to your pitch deck.
Fluency is about understanding how hospitals work — how they make money, how they lose it, who they answer to, and what keeps their executives awake at three in the morning. When you understand that, something remarkable happens. The conversation changes. The room changes. You are no longer a vendor presenting features. You are a peer presenting solutions to problems the executive already knows they have.
That is the moment deals get made.
The companies that figure this out first will win a disproportionate share of every market they compete in. The ones that do not will keep sending proposals into procurement portals and wondering why nothing is moving.
The market has already decided which kind of company wins in healthcare.
The question is which side of that line you are on.
This substack is Part 1 of a series on this strategy.
Lets begin -
You Are Not Selling to a Hospital. You Are Selling to a Balance Sheet Under Federal Pressure.
Here is something the hospital will never tell you.
When your rep walks in for that first meeting, the executive on the other side of the table is not thinking about your product. They are thinking about a number. Sometimes it is a readmission rate. Sometimes it is an operating margin that has been shrinking for eighteen months. Sometimes it is a CMS penalty they already know is coming and have not yet told their board about. Whatever the specific number is, it sits behind every question they ask, every objection they raise, and every reason they give for why the timing is not right.
Your rep is selling a product. The executive is managing a crisis.
Those two conversations almost never meet — and that is the entire problem this book exists to solve.
The hospital your rep visits is not the hospital that makes decisions.
Walk into almost any major health system in this country and you will find two hospitals occupying the same building.
The first hospital is the one your sales team can see. It has departments and service lines and administrators with titles and org charts and procurement portals. It has a clinical champion who loves your product and a supply chain director who wants three competing bids. It has a budget cycle that starts in September and a committee that meets on the third Tuesday of every month. This is the hospital most sales teams are trained to navigate. This is also the hospital where deals go to stall.
The second hospital is the one that actually makes decisions. It runs on federal reimbursement rules, quality metrics, penalty calculations, and bond covenants. Its real leadership team includes the Centers for Medicare and Medicaid Services, its accreditation body, its bondholders, and its state health department — none of whom show up on any org chart your sales team has ever seen. Every major purchasing decision in this hospital gets filtered through one question before it reaches any other: does this move our numbers in a direction that keeps us viable?
The executives who run this hospital are not being difficult when they slow-walk your deal. They are being rational. They are managing an organization that answers to more bosses than almost any other institution in the American economy, operating on margins that would shut down most businesses in other industries, under regulatory frameworks that change every year and carry eight-figure financial consequences when organizations get them wrong.
Until your team understands that hospital — the real one — you are not in the conversation.
The morning the penalty notice arrives.
Let me show you what I mean.
It is early October. A CFO at a regional health system opens her email and finds the annual Hospital Readmissions Reduction Program update from CMS. The notice tells her that her system’s readmission rate for heart failure patients puts them in the penalty tier for the coming fiscal year. The penalty is $2.3 million — not catastrophic, but still very serious. Even for a system already running a 1.8 percent operating margin, where a $2.3 million penalty does not just affect the budget — it affects what gets delayed, what gets cut, and who has to explain it to the board. She has until her board meeting in six weeks to have a plan.
She does not reach for your brochure.
She calls her VP of Quality. She calls her CMO. She pulls the data on which service lines are driving the readmissions and which patient populations are most at risk. She starts asking questions about what other health systems in her peer group are doing and whether any vendor solutions have actually moved the needle on this metric in a documented, replicable way.
Now. If your rep happens to reach out to this CFO in the next two weeks — with a message that demonstrates a precise understanding of HRRP penalty calculations, that speaks to the specific DRGs most likely driving her readmission rate, and that references documented outcomes from comparable health systems — that rep gets a meeting. Not because they were lucky. Because they were fluent.
If your rep sends a generic outreach about ‘improving patient outcomes through innovative care coordination technology,’ that email gets deleted before she reaches her second cup of coffee.
Same product. Completely different result. The only variable is whether the seller could speak to the problem the executive was actually trying to solve that morning.
Six programs, one mission.
The HRRP story is not an edge case. It is the operating reality for every hospital in the country right now — multiplied across six major CMS programs running simultaneously.
The Hospital Readmissions Reduction Program is penalizing hospitals for excess readmissions across specific conditions, with more than $550 million in penalties distributed annually.
The Hospital Value-Based Purchasing program puts two percent of every hospital’s Medicare reimbursement at risk based on quality and patient experience scores.
The TEAM model — Transforming Episode Accountability Model — is making bundled payment accountability mandatory for surgical episodes at hundreds of hospitals, reshaping how those institutions think about the entire care continuum around a procedure, including every device and technology involved.
The ACCESS program is building a ten-year chronic care infrastructure covering two thirds of Medicare beneficiaries.
The Rural Health Transformation program represents a $50 billion federal investment reshaping how smaller hospitals operate and what they can afford to buy.
The IOTA kidney transplant model creates $15,000 per-case upside for transplant centers that hit performance targets.
Every one of these programs is a commercial opportunity for the right company with the right message. Every one of them is invisible to a sales team that has not done the work to understand what they mean and how they land inside a health system.
The fluent seller reads a CMS program update the way a financial analyst reads an earnings report — looking not just at what it says, but at who inside the hospital now has a new problem to solve, a new budget to justify, or a new metric to move. That is where the conversation starts. That is where the deal begins.
The decision you think you are targeting has already happened.
Here is the part that surprises most sales leaders when I tell them.
By the time a hospital executive agrees to evaluate a vendor solution, the real decision — the strategic decision about what kind of problem needs solving and what kind of investment it warrants — has already been made. That decision happened in a leadership meeting your rep was not in. It happened in response to a regulatory update your rep did not read. It happened because a penalty hit, a quality score dropped, or a new CMS mandate landed that changed the math on something the executive had been deferring for two years.
The companies that are fluent in healthcare are in the room before the formal evaluation starts. They are cited in the leadership conversation. Their frameworks are on the whiteboard. Their language is in the memo the CMO sends to the CFO. They did not get there through better prospecting sequences or more aggressive follow-up cadences. They got there because they had already demonstrated, through every piece of content they published and every conversation their team had, that they understood how hospitals work.
The vendor evaluation that follows is not where they win the deal. It is where they confirm what the executive already decided.
The Fluency Gap and what it is costing you.
The gap between where most healthcare sales teams operate and where they need to operate is not a skills gap. It is not a product gap. It is not a pricing gap.
It is a fluency gap.
And it compounds every quarter. Every meeting where your rep cannot speak to the regulatory context costs you positioning. Every proposal that leads with features instead of financial outcomes costs you credibility. Every sales cycle that stretches to fourteen months because no one on your team could connect your solution to the right pressure point at the right level of the organization — that is the fluency gap expressing itself as lost revenue.
The good news is that this is a solvable problem. Not through a one-day training. Not through a glossary of healthcare acronyms stapled to the back of your sales playbook. Through a genuine, structural change in how your team understands the market it is operating in.
The series that follow will show you exactly what that looks like.
But first, you need to see the full shape of the problem — because the fluency gap is not just a sales team issue. It is a company design issue. And understanding that distinction is what separates the organizations that fix it from the ones that keep scheduling remedial training and wondering why nothing changes.
THE FLUENCY MOVE
Pull the CMS HRRP penalty data for your top five target accounts. It is publicly available. Find the penalty tier each health system landed in for the current fiscal year, identify which conditions are driving their readmission rates, and write a two-paragraph note that connects your solution to that specific pressure — in the CFO’s language, not yours. Do not send it yet. Just write it. If you cannot write it, you have found the gap. That is where the work starts.
You can bring Fluency in Healthcare to your company -